Kyverna Therapeutics, Inc. (KYTX) Tops Q1 EPS by 38c

Kyverna Therapeutics, Inc. (NASDAQ: KYTX) reported Q1 EPS of ($0.66), $0.38 better than the analyst estimate of ($1.04).

For earnings history and earnings-related data on Kyverna Therapeutics, Inc. (KYTX) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Popular stocks with increasing option volume: MU PLTR DELL INTC SPCX PCG AVGO SOFI MSTR NFLX IREN ORCL
• Compass Diversified (CODI)7500 contracts of December 13 calls trade